Utepreva Introduces FDA 510(k)-Cleared Endometrial Sampler Designed to Support Early Detection of Endometrial Cancer

The innovative device supports early diagnosis when survival outcomes are most favorable. NEW YORK, April 22, 2026 /PRNewswire/ -- Utepreva LLC today announced the launch of the Utepreva Endometrial Sampler, a patented, FDA 510(k)-cleared, single-use endometrial sampling device engineered...